Glaucoma patients exhibit elevated TGF-β concentrations in the aqueous humor and trabecular meshwork, suggesting that targeting TGF-β signaling represents a key therapeutic strategy for preventing postoperative fibrosis (79, 80). The gene discussed is TGFB1; the disease is glaucoma.